Sort   by:  
 Page size 
ModelsBesozzi2012 - Oscillatory regimes in the Ras/cAMP/PKA pathway in S.cerevisiae
Besozzi2012 - Oscillatory regimes in the Ras/cAMP/PKA pathway in S.cerevisiae Mechanistic model of the Ras/cAMP/PKA in yeast S.cerevisiae. The Ras/cAMP/PKA pathway plays a major role in the regulation of metabolism, stress resistance and cell cycle progress and is tightly regulated...
2024-09-02 | BIOMD0000000478 | BioModels
UnknownPrognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.
Not available
S-EPMC3255561 | biostudies-literature
UnknownDiscrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories.
Not available
S-EPMC8665327 | biostudies-literature
UnknownRings and Bricks: Expression of Cohesin Components is Dynamic during Development and Adult Life.
Not available
S-EPMC5855660 | biostudies-literature
UnknownEfficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy.
Not available
S-EPMC6686411 | biostudies-literature
UnknownPMCA-Based Detection of Prions in the Olfactory Mucosa of Patients With Sporadic Creutzfeldt-Jakob Disease.
Not available
S-EPMC8990253 | biostudies-literature
UnknownThe prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial.
Not available
S-EPMC8253801 | biostudies-literature
UnknownLoss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study.
Not available
S-EPMC7731769 | biostudies-literature
UnknownAdjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.
Not available
S-EPMC10227592 | biostudies-literature
UnknownGRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial.
Not available
S-EPMC10243192 | biostudies-literature
Sort   by:  
 Page size